You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Eosinophilic Asthma

Showing 1 - 25 of 4,308
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in Jacksonville (Dexpramipexole DiHCl, Placebo)

Recruiting
  • Eosinophilic Asthma
  • +2 more
  • Dexpramipexole Dihydrochloride
  • Placebo
  • Jacksonville, Florida
    Research Site 30001-291
Apr 17, 2023

Eosinophilic Asthma Trial in Taipei (AD17002, Placebo)

Not yet recruiting
  • Eosinophilic Asthma
  • Taipei, Taiwan
    Taipei Medical University Hospital
Aug 16, 2023

Severe Eosinophilic Asthma Phenotypes During Childhood Have

Not yet recruiting
  • Severe Asthma
  • Asthma in Children
    • Paris, France
      Allergy Department, Trousseau Hospital
    Feb 28, 2023

    Chronic Rhinosinusitis, Nasal Polyps and Comorbid Severe

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • +2 more
    • Mepolizumab 100 MG
    • Athens, Attiki, Greece
    • +1 more
    Sep 29, 2023

    Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Attack Trial in United States (Dexpramipexole DiHCl, Placebo)

    Recruiting
    • Eosinophilic Asthma
    • +2 more
    • Dexpramipexole Dihydrochloride
    • Placebo
    • West Covina, California
    • +7 more
    Mar 1, 2023

    Eosinophilic Asthma, Asthma; Eosinophilic, Asthma Trial in United States (Dexpramipexole DiHCl, Placebo)

    Recruiting
    • Eosinophilic Asthma
    • +2 more
    • Dexpramipexole Dihydrochloride
    • Placebo
    • West Covina, California
    • +7 more
    Mar 1, 2023

    Patient-Reported OUTcomes of Benralizumab in Real-World Use in

    Not yet recruiting
    • Severe Asthma
      • (no location specified)
      Nov 17, 2022

      Asthma; Eosinophilic Trial (Mepolizumab 100 MG)

      Recruiting
      • Asthma
      • Eosinophilic Asthma
      • Mepolizumab 100 MG
      • Ferrol, A Coruña, Spain
      • +4 more
      Sep 5, 2022

      Asthma Trial in Worldwide (Benralizumab, Placebo)

      Not yet recruiting
      • Asthma
      • Owensboro, Kentucky
      • +6 more
      Jan 11, 2023

      Real World Evidence of Benralizumab in Eosinophilic Severe

      Recruiting
      • Severe Eosinophilic Asthma
        • Moscow, Russian Federation
          City clinical hospital No57
        Aug 8, 2022

        Benralizumab in Real-World Use in Severe Eosinophilic Asthma

        Recruiting
        • Asthma
          • Changhua City, Taiwan
          • +7 more
          Feb 16, 2023

          Gene Transcription and Immunophenotypes Following Mepolizumab

          Active, not recruiting
          • Eosinophilic Asthma
            • Rochester, Minnesota
              Mayo Clinic in Rochester
            Jan 17, 2023

            Asthma Trial in Marseille, Montpellier (48 weeks of Benralizumab, Computed tomography)

            Active, not recruiting
            • Asthma
            • 48 weeks of Benralizumab
            • Computed tomography
            • Marseille, France
            • +1 more
            Sep 8, 2022

            Asthma Trial in Shanghai (610 30mg group, 610 100mg group, 610 300mg group)

            Active, not recruiting
            • Asthma
            • 610 30mg group
            • +5 more
            • Shanghai, Shanghai, China
              Shanghai General Hospital
            Oct 17, 2022

            Non-Eosinophilic Biological Effects of IL-5

            Not yet recruiting
            • Asthma
              • (no location specified)
              Sep 6, 2023

              Response to Mepolizumab in Severe Eosinophilic Asthma

              Not yet recruiting
              • Asthma; Eosinophilic
                • (no location specified)
                Feb 4, 2022

                Capture Clinical and Patient Centered Outcomes in Severe

                Recruiting
                • Severe Eosinophilic Asthma
                • Alexandroupolis, Greece
                • +15 more
                Aug 5, 2022

                Asthma; Eosinophilic Trial in Stara Zagora (Treatment A, Treatment B, Treatment C)

                Terminated
                • Asthma; Eosinophilic
                • Treatment A
                • +3 more
                • Stara Zagora, Bulgaria
                  Medical Center "Nov Rehabilitatsionen Tsentar" Ltd
                Mar 30, 2022

                Severe Eosinophilic Asthma Treated With Benralizumab

                Recruiting
                • Asthma; Eosinophilic
                  • Sevilla, Spain
                    Hospital Universitario Virgen Macarena
                  Nov 15, 2021

                  Mepolizumab on Structural and Inflammatory Cells in Severe

                  Not yet recruiting
                  • Asthma; Eosinophilic
                    • (no location specified)
                    Nov 22, 2021

                    Bronchial Asthma, Bronchiectasis Trial in Catania (Mepolizumab)

                    Recruiting
                    • Bronchial Asthma
                    • Bronchiectasis
                    • Mepolizumab
                    • Catania, Italy
                      AOU Policlinico "G. Rodolico-Sto arrivando!n Marco"
                    Jan 11, 2022

                    Asthma, Severe Eosinophilic Asthma Trial in Worldwide (Symbicort®, Fasenra®, Ventolin®)

                    Active, not recruiting
                    • Asthma
                    • Severe Eosinophilic Asthma
                    • Brest Cedex, France
                    • +22 more
                    Aug 24, 2022

                    Non-Eosinophilic Asthma Trial in United States (AVTX-002, Placebo)

                    Recruiting
                    • Non-Eosinophilic Asthma
                    • Tucson, Arizona
                    • +23 more
                    Dec 7, 2022

                    Severe Uncontrolled Asthma Trial in Japan, United States (Benralizumab)

                    Completed
                    • Severe Uncontrolled Asthma
                    • Los Angeles, California
                    • +14 more
                    Oct 7, 2022

                    Mepolizumab on Severe Refractory Eosinophilic Asthma With or

                    Recruiting
                    • Asthma
                    • +2 more
                    • Telese Terme, BN, Italy
                      Istituti Clinici Scientifici Maugeri IRCCS
                    Dec 20, 2021